Fentanyl Hearing Starring Country Music Star Jelly Roll Talks Sanctions; Mainly Threatens China
This week’s Senate Banking Committee hearing on fentanyl was high on celebrity, short on solutions.
Menu
Senator Tillis Says U.S. Needs CHIPS Act for Generic Drugs in Short Supply
In Senate hearing: imported generic drugs facing consistent drug shortages need a government incentive program to help labs make life-saving commodity drugs domestically.
Is American Made Medication Preferred Over Imports?
A recent study suggests that Americans prefer locally produced medications if they are unclear where the product was made or if the lab has received bad reviews from an FDA inspection.
India Lab Recalls 27 Eye Drops From U.S. Pharmacies
Another Indian lab recalling eye drops following recalls in October and instances of blindness caused by other imports from India in March.
Congress Can Fix the Dangerous Dependence on Imported Pharmaceuticals
In the wake of the COVID pandemic, consumers have become painfully aware of America’s heavy dependence on imports. The recent Amoxicillin shortage in hospitals has made this particularly clear since the United States is now highly reliant on imported antibiotics and other lifesaving medications. The United States is so deep in the hole when it…
CPA Applauds Congresswoman Tenney’s PILLS Act, Legislation to Boost U.S. Domestic Production of Generic Medicines
WASHINGTON — The Coalition for a Prosperous America (CPA) today applauded the introduction of the Producing Incentives for Long-term Production of Lifesaving Supply of Medicines (PILLS) Act by Congresswoman Claudia Tenney (R-NY) which would incentivize the strategic reshoring of U.S. domestic production of generic medicines with a domestic production-based tax credit, domestic content bonus credit,…
Candidate Trump Announces Plans to Reshore Essential Medicines to Avoid Drug Shortages
Trump’s call to reshore pharmaceutical production, especially critical medicine in short supply, will set the table for other presidential candidates. Reshoring America’s medicine supply chain is increasingly mainstream, and an easy sell to voters.
FDA Allows Uninspected China Lab to Sell Cancer Drugs in the US
A Chinese cancer drug maker that has not been inspected by the FDA since 2018 is selling chemotherapy drugs to the U.S. due to shortages. When will the U.S. meet its critical medication needs?
To Fight Drug Shortages FDA Has an Idea: Import More Inspection-Free Drugs
The balance between scarcity and supply favors supply, even if that means importing drugs from labs the FDA has not inspected.
House Committee Holds Hearing on Drug Shortages
The U.S. is increasingly reliant on imported drugs from uninspected labs. It’s not safe. What can be done about it?
